news details |
|
|
Mobile app for hemophilia patients launched | | | Early Times Report JAMMU, Dec 11: An innovative mobile app, DosEdge for hemophilia has been launched today. The new free mobile app aids healthcare professionals in determining the appropriate dosage of antihemophilic factor/drug. DosEdge safeguards dosage accuracy and reduces the incidence of error, thereby helping physicians develop personalized dosing regimens tailored to specific needs of their respective patients. The app is available to healthcare professionals through the Apple App Store and Google Play Store. The app is free, does not require an active internet connection, has a simple user interface and needs minimal data inputs. However, the app uses data analysis to make accurate and critical dosage calculations for factor replacement. With just a few clicks, the app enables healthcare professionals to assess their patients' accurate factor dosage requirement and helping them retain full control over their prescription practice. |
|
|
|
|
|
|
|
|
|
|
|
|
![Early Times Android App](etad2.jpg) |
|
|
|
STOCK UPDATE |
|
|
|
BSE
Sensex |
![](http://chart.finance.yahoo.com/t?s=%5ENSEI&lang=en-IN®ion=IN&width=200&height=135) |
NSE
Nifty |
|
|
|
CRICKET UPDATE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|